For All Mankind
Not our company. However, Vermillion is on that list. Through the use of our SVMs, Vermillion developed the only clinical laboratory which identifies a protein fingerprint for ovarian cancer. Ciphergen/Vermillion’s OVA 1 test was once licensed exclusively to Quest Diagnostics – the best in its space with a 15-billion-dollar market cap. Until they opened their own lab (Aspira) which continues to be a formidable competitor in the women’s genetic testing sub-sector to this day.
>>>In 2006, Health Discovery Corporation sued Ciphergen Biosystems in Federal District Court for infringement of several of its patents covering the use of support vector machines (SVMs) for the discovery of biomarkers. As alleged in the complaint, Ciphergen’s researchers had used SVMs to identify the most promising biomarkers for diagnosis of ovarian cancer, the results of which had been reported in a number of medical publications. The settlement agreement, through which Ciphergen was granted a limited license to continue its use of the Company’s SVM technology only in conjunction with its protein based SELDI mass spectrometry technology, was inked in July 2007. No rights were granted under the license to use HDC’s SVM technology for gene-based molecular diagnostic discovery, digital pathology interpretations, digital radiology interpretation nor any other discovery use outside of the very narrow field of SELDI-based protein discovery. Vermillion went on to further develop these biomarkers into the OVA1™ test, which was approved by the FDA in September 2009 and exclusively licensed to Quest Diagnostics. Based on these favorable developments, Vermillion recently emerged from bankruptcy and has enjoyed phenomenal growth in its share prices.<<<
Even the mere mention that this is a scam shows a profound lack of DD, critical thinking skills or honesty.
